Nitric oxide synhase inhibitors effects on acute and chronic L-dopa-induced dyskinesias in the 6-OHDA rat model of Parkinson's disease

被引:0
作者
Padovan-Neto, F. E.
Echeverry, M. B.
Tumas, V.
Del Bel, E. A.
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S247 / S247
页数:1
相关论文
共 50 条
  • [21] Globus pallidus, but not entopeduncular nucleus, 6-OHDA-induced lesion attenuates L-Dopa-induced dyskinesia in the rat model of Parkinson's disease
    Marin, Concepcio
    Bonastre, Merce
    Fuentes, Mireya
    Mullol, Joaquim
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2020, 197
  • [22] AMPA antagonists attenuate L-DOPA-induced abnormal involuntary movements in the 6-OHDA-lesioned rat model of Parkinson's disease
    Kobylecki, C.
    Ravenscroft, P.
    Crossman, A.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S140 - S140
  • [23] Alternative splicing of AMPA receptor subunits in the 6-OHDA-lesioned rat model of Parkinson's disease and L-DOPA-induced dyskinesia
    Kobylecki, Christopher
    Crossman, Alan R.
    Ravenscroft, Paula
    EXPERIMENTAL NEUROLOGY, 2013, 247 : 476 - 484
  • [24] Nicotinic Receptor Agonists Reduce L-DOPA-Induced Dyskinesias in a Monkey Model of Parkinson's Disease
    Zhang, Danhui
    Mallela, Archana
    Sohn, David
    Carroll, F. Ivy
    Bencherif, Merouane
    Letchworth, Sharon
    Quik, Maryka
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2013, 347 (01) : 225 - 234
  • [25] The dopaminergic stabilizer pridopidine decreases expression of L-DOPA-induced locomotor sensitisation in the rat unilateral 6-OHDA model
    Ponten, Henrik
    Kullingsjo, Johan
    Sonesson, Clas
    Waters, Susanna
    Waters, Nicholas
    Tedroff, Joakim
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 698 (1-3) : 278 - 285
  • [26] Comparison of rating scales used to evaluate L-DOPA-induced dyskinesia in the 6-OHDA lesioned rat
    Breger, Ludivine S.
    Dunnett, Stephen B.
    Lane, Emma L.
    NEUROBIOLOGY OF DISEASE, 2013, 50 : 142 - 150
  • [27] Effects of histone acetyltransferase inhibitors on l-DOPA-induced dyskinesia in a murine model of Parkinson's disease
    Ryu, Young-Kyoung
    Park, Hye-Yeon
    Go, Jun
    Kim, Yong-Hoon
    Hwang, Jung Hwan
    Choi, Dong-Hee
    Noh, Jung-Ran
    Rhee, Myungchull
    Han, Pyung-Lim
    Lee, Chul-Ho
    Kim, Kyoung-Shim
    JOURNAL OF NEURAL TRANSMISSION, 2018, 125 (09) : 1319 - 1331
  • [28] Chronic SKF83959 induced less severe dyskinesia and attenuated L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease
    Zhang, Hai
    Ma, Liqun
    Wang, Fang
    Chen, Jianguo
    Zhen, Xuechu
    NEUROPHARMACOLOGY, 2007, 53 (01) : 125 - 133
  • [29] 7-NITROINDAZOLE EFFECTS ON L-DOPA-INDUCED DYSKINESIAS AND ON STRIATAL NITRIC OXIDE PRODUCTION
    Padovan-Neto, F. E.
    Romano, A. C.
    Ferreira, F.
    Del Bel, E. A.
    JOURNAL OF NEUROCHEMISTRY, 2009, 110 : 47 - 47
  • [30] The effect of piribedil on l-DOPA-induced dyskinesias in a rat model of Parkinson’s disease: differential role of α2 adrenergic mechanisms
    Manfred Gerlach
    Paul Halley
    Peter Riederer
    Maarten van den Buuse
    Journal of Neural Transmission, 2013, 120 : 31 - 36